Cosentyx is indicated for the treatment of: moderate to severe plaque psoriasis (PsO) in adults, adolescents and children from the age of 6 years who are candidates for systemic therapy; active psoriatic arthritis in adult patients, alone or in combination with MTX, when the response to previous DMARD therapy has been inadequate.
Individual patient dosing may vary - please consult the Prescribing Information for full details.
Introducing the new 300 mg autoinjector pen: All the benefits of the Complete Cosentyx Approach™* in adult plaque psoriasis in ONE UnoReady® pen1–3
UnoReady® 300 mg pen:
Similar administration steps as the SensoReady® 150 mg pen, with a few differences.1,4,5


The UnoReady® 300 mg pen will be available via the homecare channels and your pharmacy.
If you would like to order a demo-kit or for further information on the UnoReady® 300 mg pen, please contact us here
Convenient dosing schedule that delivers all the benefits of Cosentyx
*The Complete Cosentyx Approach™ is defined as efficacy in both skin and persistent nail and scalp PsO, as well as psoriatic arthritis, and improvements in quality of life.
†Individual patient dosing may vary - please consult the Prescribing Information for full details.
‡N=37, moderate-to-severe plaque psoriasis patients at Week 28.2
§In a clinical study, adverse events with the preferred term injection-site bruising or injection-site pain due to administration of Cosentyx using the UnoReady® pen over 52 weeks.
DMARD, disease-modifying anti-rheumatic drugs; MTX, methotrexate; TNF, tumour necrosis factor.
References
- Cosentyx Summary of Product Characteristics.
- Novartis data on file. CAIN457A2325 Data Analysis Report. Satisfaction with self-injection. December 2020.
- Novartis data on file. CAIN457A2325 Data Analysis Report. Injection site reaction rate. December 2020.
- Cosentyx EPAR Product Information. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/cosentyx [Accessed November 2021].
- Paul C, et al. J Eur Acad Dermatol Venereol 2015;29(6):1082–1090.